Article Details

Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 ...

Retrieved on: 2022-08-24 10:20:37

Tags for this article:

Click the tags to see associated articles and topics

Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 .... View article details on hiswai:

Excerpt

... which marks a solid step of Innovent's global innovation strategy. The company will also accelerate the development of more innovative ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up